This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Scott, R. R. Articles by Miller, W. L. Search for Related Content PubMed PubMed Citation Articles by Scott, R. R. Articles by Miller, W. L. Related Collections Adrenal and Hypertension Pediatric Endocrinology Metabolism

Apparent Manifesting Heterozygosity in P450 Oxidoreductase Deficiency and Its Effect on Coexisting 21-Hydroxylase Deficiency

Division of Endocrinology (R.R.S., L.G.G., N.H., W.L.M.), Department of Pediatrics, University of California, San Francisco, San Francisco, California 94143; and Endocrinology Service and Research Center (R.R.S., G.V.V.), Sainte-Justine Hospital, and Department of Pediatrics, University of Montreal, Montreal, Canada H3T 1C5

Address all correspondence and requests for reprints to: Prof. Walter L. Miller, Pediatric Endocrinology, 672-S, University of California, San Francisco, San Francisco, California 94143-0434. E-mail: wlmlab{at}ucsf.edu.

Context: P450 oxidoreductase (POR) deficiency is a disorder of steroidogenesis affecting the microsomal P450 enzymes that use POR as an electron donor. The clinical presentation is variable; patients can be asymptomatic or can present with genital anomalies and the Antley-Bixler syndrome, characterized by craniosynostosis and other bony anomalies. Obligately heterozygous parents are normal. Combined POR and 21-hydroxylase deficiencies have not been reported.

Objective: The aim was to explore the manifestations of combined deficiencies of 21-hydroxylase and POR and to search for lesions in apparent manifesting POR heterozygotes.

Patients and Methods: A newborn female had craniosynostosis, severe salt wasting, minimal virilization, grossly elevated 17OH-progesterone, and minimally elevated androgens. DNA encoding 21-hydroxylase, POR, and fibroblast growth factor receptor 2 was sequenced. For POR, the first untranslated exon (exon 1U), 5' flanking DNA, and most introns were sequenced in five apparent manifesting POR heterozygotes.

Results: CYP21B mutations were found on both alleles, proving classical 21-hydroxylase deficiency. Fibroblast growth factor receptor 2 exons 8 and 10 were normal. A POR mutation, A287P, was found only on the maternal allele. Five previously reported patients had POR mutations found on only one allele, but their clinical characteristics were indistinguishable from patients with mutations on both alleles. Sequencing of exon 1U, 274 bp of POR 5' flanking DNA, and 12 of the 15 POR introns did not identify additional mutations affecting gene expression or splicing.

Conclusion: Manifesting heterozygosity is a possible feature of POR deficiency and may ameliorate the findings in coexisting 21-hydroxylase deficiency.

This article has been cited by other articles:

				L. G. Gomes, N. Huang, V. Agrawal, B. B. Mendonca, T. A. S. S. Bachega, and W. L. Miller The Common P450 Oxidoreductase Variant A503V Is Not a Modifier Gene for 21-Hydroxylase Deficiency J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2913 - 2916. [Abstract] [Full Text] [PDF]

				A. V. Pandey, P. Kempna, G. Hofer, P. E. Mullis, and C. E. Fluck Modulation of Human CYP19A1 Activity by Mutant NADPH P450 Oxidoreductase Mol. Endocrinol., October 1, 2007; 21(10): 2579 - 2595. [Abstract] [Full Text] [PDF]